Haleon Change in Accounts Receivable 2023-2024 | HLN
Haleon annual/quarterly change in accounts receivable history and growth rate from 2023 to 2024. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
- Haleon change in accounts receivable for the quarter ending September 30, 2024 was $0M, a 0% increase year-over-year.
- Haleon change in accounts receivable for the twelve months ending September 30, 2024 was $0M, a 0% increase year-over-year.
- Haleon annual change in accounts receivable for 2024 was $-0.399B, a 943.5% decline from 2023.
- Haleon annual change in accounts receivable for 2023 was $0.047B, a 144.96% decline from 2022.
- Haleon annual change in accounts receivable for 2022 was $-0.105B, a 0% decline from 2021.
| Haleon Annual Change in Accounts Receivable (Millions of US $) |
|
|---|---|
| 2024 | $-399 |
| 2023 | $47 |
| 2022 | $-105 |
| 2021 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $43.526B | $14.355B |
| Haleon plc engages in the research and development, manufacture and sale of various consumer healthcare products principally in North America, Europe, the Middle East, Africa, Latin America and the Asia Pacific. It provides therapeutic oral health, pain relief, respiratory health, digestive health and other products, as well as vitamins, minerals and supplements. Haleon plc is based in Brentford, the United Kingdom. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $225.215B | 26.41 |
| Boston Scientific (BSX) | United States | $151.880B | 36.22 |
| Stryker (SYK) | United States | $144.875B | 29.49 |
| EssilorLuxottica (ESLOY) | France | $142.491B | 0.00 |
| Medtronic (MDT) | Ireland | $119.092B | 16.89 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.952B | 0.00 |
| ResMed (RMD) | United States | $42.208B | 30.19 |
| GE HealthCare Technologies (GEHC) | United States | $34.393B | 16.17 |
| Agilent Technologies (A) | United States | $34.170B | 22.28 |
| Terumo (TRUMY) | Japan | $27.923B | 33.09 |
| Koninklijke Philips (PHG) | Netherlands | $26.278B | 17.38 |
| Insulet (PODD) | United States | $21.729B | 72.80 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.447B | 13.02 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.109B | 0.00 |
| Baxter (BAX) | United States | $12.383B | 9.57 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.771B | 28.55 |
| Lantheus Holdings (LNTH) | United States | $3.657B | 9.89 |
| Envista Holdings (NVST) | United States | $3.583B | 25.07 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.269B | 14.50 |
| Perrigo (PRGO) | Ireland | $3.255B | 8.13 |
| ICU Medical (ICUI) | United States | $2.817B | 19.18 |
| Haemonetics (HAE) | United States | $2.596B | 11.59 |
| LeMaitre Vascular (LMAT) | United States | $2.154B | 46.19 |
| Curaleaf Holdings (CURLF) | Canada | $2.065B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.899B | 81.54 |
| QuidelOrtho (QDEL) | United States | $1.839B | 11.57 |
| AtriCure (ATRC) | United States | $1.824B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.376B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.316B | 18.75 |
| Phibro Animal Health (PAHC) | United States | $1.255B | 16.04 |
| BioLife Solutions (BLFS) | United States | $1.230B | 2568.00 |
| Neogen (NEOG) | United States | $1.203B | 19.10 |
| Acuren (TIC) | United States | $1.169B | 0.00 |
| Valneva SE (VALN) | France | $0.950B | 0.00 |
| InMode (INMD) | Israel | $0.926B | 8.57 |
| Kestra Medical Technologies (KMTS) | United States | $0.816B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.700B | 0.00 |
| SNDL (SNDL) | Canada | $0.562B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.547B | 0.00 |
| Surmodics (SRDX) | United States | $0.543B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.532B | 0.00 |
| ZimVie (ZIMV) | United States | $0.532B | 20.49 |
| VAREX IMAGING (VREX) | United States | $0.444B | 15.27 |
| CeriBell (CBLL) | United States | $0.437B | 0.00 |
| Evolus (EOLS) | United States | $0.421B | 0.00 |
| Owens & Minor (OMI) | United States | $0.412B | 3.65 |
| Capricor Therapeutics (CAPR) | United States | $0.379B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.342B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.336B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.330B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.312B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.284B | 21.56 |
| Sanara MedTech (SMTI) | United States | $0.284B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.272B | 0.00 |
| Omeros (OMER) | United States | $0.264B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.262B | 0.00 |
| Cerus (CERS) | United States | $0.255B | 0.00 |
| Brainsway (BWAY) | Israel | $0.240B | 48.85 |
| Quanterix (QTRX) | United States | $0.223B | 0.00 |
| Organigram Global (OGI) | Canada | $0.214B | 0.00 |
| Exagen (XGN) | United States | $0.213B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.208B | 0.00 |
| High Tide (HITI) | Canada | $0.200B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.190B | 15.88 |
| Biote (BTMD) | United States | $0.168B | 5.03 |
| FitLife Brands (FTLF) | United States | $0.152B | 18.75 |
| TriSalus Life Sciences (TLSI) | United States | $0.149B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.128B | 0.00 |
| MacroGenics (MGNX) | United States | $0.105B | 0.00 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.095B | 12.19 |
| Apyx Medical (APYX) | United States | $0.089B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Safety Shot (SHOT) | United States | $0.076B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| MariMed (MRMD) | United States | $0.051B | 0.00 |
| Veru (VERU) | United States | $0.050B | 0.00 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 34.33 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.39 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |